We are live on ! Find out more
SNOAW

Sonoma Pharmaceuticals, Inc. Warrants
SNOAW

Delisted

SNOAW was delisted on the 22nd of January, 2020.

Back to rankings

2 hedge funds and large institutions have $2K invested in Sonoma Pharmaceuticals, Inc. Warrants in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less funds holding

Funds holding: 3 → 2 (-1)

86% less capital invested

Capital invested by funds: $14K → $2K (-$12K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
MIG
Mariner Investment Group
New York
-$10K
2
UBS Group
UBS Group
Switzerland
-$1.67K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$1K -$1.67K -3,986 -54%
Bank of America
2
Bank of America
North Carolina
$1K – – –
MIG
3
Mariner Investment Group
New York
– -$10K -22,127 Closed

SNOAW Hedge Fund Activity: Q3 2017 in Review

2 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) for Q3 2017, worth a combined $2K — down 86% from $14K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SNOAW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Mariner Investment Group, exiting entirely with an estimated $10K sold.

  • 2 institutional investors held Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) as of Q3 2017, down from 3 in Q2 2017.
  • Funds reported $2K of Sonoma Pharmaceuticals, Inc. Warrants stock for Q3 2017, down 86% quarter-over-quarter.
  • 0 funds opened new Sonoma Pharmaceuticals, Inc. Warrants positions in Q3 2017 and 1 closed out, a net change of -1 holder.
  • The largest Sonoma Pharmaceuticals, Inc. Warrants seller in Q3 2017 was Mariner Investment Group, an estimated $10K sold.

Based on aggregated 13F filings for Q3 2017.